Form 4: Orchestra BioMed Holdings CEO Hochman Receives 100,000 Restricted Stock Units
SEC Form 4
David P. Hochman, CEO and Chairperson of Orchestra BioMed Holdings, Inc., was granted 100,000 restricted stock units (RSUs) on May 8, 2024.
Summary
- On May 8, 2024, David P. Hochman, CEO and Chairperson of Orchestra BioMed Holdings, Inc., received an award of 100,000 restricted stock units (RSUs).
- These RSUs represent a contingent right to receive one share of Common Stock per RSU.
- 15,000 RSUs will vest on June 10, 2025.
- The remaining 85,000 RSUs will vest in equal installments on various dates from September 10, 2025, to June 10, 2028, contingent upon continuous service.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing related to executive compensation. It's neutral in tone and reflects a common practice. The sentiment is slightly positive as it indicates alignment of management interests with shareholders.
Positives
- The vesting schedule of the RSUs incentivizes long-term commitment from the CEO.
Risks
- The value of the RSUs is dependent on the future stock price of Orchestra BioMed Holdings.
Future Outlook
The vesting of the RSUs is contingent upon the Reporting Person's continuous service through the specified dates.
Industry Context
Granting RSUs is a common practice in the biotech industry to align executive interests with shareholder value and incentivize long-term performance.
Comparison to Industry Standards
- Executive compensation packages, including RSU grants, vary significantly across the biotech industry depending on company size, stage of development, and performance.
- Comparing Orchestra BioMed's executive compensation to peers like Medtronic or Boston Scientific would provide a better understanding of its relative competitiveness.
- Benchmarking against similar-sized companies in the medical device space would offer a more relevant comparison.
Stakeholder Impact
- The RSU grant aligns the CEO's interests with those of the shareholders, incentivizing him to increase the company's value.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Date of transaction: David P. Hochman received 100,000 restricted stock units. |
| 05/10/2024 | Date of Form 4 filing. |
| 06/10/2025 | Vesting date for 15,000 RSUs. |
| 09/10/2025 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 11/10/2025 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 12/10/2025 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 06/10/2026 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 09/10/2026 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 12/10/2026 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 03/22/2027 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 06/10/2027 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 09/10/2027 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 12/10/2027 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 03/22/2028 | Vesting date for a portion of the remaining 85,000 RSUs. |
| 06/10/2028 | Final vesting date for the remaining 85,000 RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.